Career history of Shelley Kim Fraser
Former positions of Shelley Kim Fraser
Companies | Position | Start | End |
---|---|---|---|
INDUCTION HEALTHCARE GROUP PLC | Director/Board Member | 2020-03-01 | 2021-01-18 |
Director of Finance/CFO | 2019-08-15 | 2021-01-18 | |
HVIVO PLC | Director of Finance/CFO | 2018-09-19 | 2019-07-30 |
Corporate Officer/Principal | - | 2018-09-19 | |
Corporate Secretary | 2018-12-31 | 2019-07-30 | |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Director of Finance/CFO | - | - |
Statistics
International
United Kingdom | 4 |
Operational
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 1 |
Corporate Secretary | 1 |
Sectoral
Commercial Services | 2 |
Technology Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
INDUCTION HEALTHCARE GROUP PLC | Technology Services |
Private companies | 2 |
---|---|
hVIVO Ltd.
hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Shelley Kim Fraser
- Experience